UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Primary afferent tachykinins are required to experience moderate to intense pain

Nature (London), 1998-03, Vol.392 (6674), p.390-394

1998

Volltextzugriff (PDF)

Acquisition and quantification pipeline for in vivo hyperpolarized 13C MR spectroscopy

Magnetic resonance in medicine, 2022-04, Vol.87 (4), p.1673-1687

2022

Volltextzugriff (PDF)

Acquisition and quantification pipeline for in vivo hyperpolarized 13 C MR spectroscopy

Magnetic resonance in medicine, 2022-04, Vol.87 (4), p.1673-1687

2022

Volltextzugriff (PDF)

Cell fate analysis in fetal mouse lung reveals distinct pathways for TI and TII cell development

American journal of physiology. Lung cellular and molecular physiology, 2019-11, Vol.317 (5), p.L653-L666

2019

Volltextzugriff (PDF)

Non-invasive assessment of telomere maintenance mechanisms in brain tumors

Nature communications, 2021-01, Vol.12 (1), p.92-92, Article 92

2021

Volltextzugriff (PDF)

Hyperpolarized δ-[1- 13 C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastoma

Scientific reports, 2023-03, Vol.13 (1), p.5190-5190, Article 5190

2023

Volltextzugriff (PDF)

Imaging 6-Phosphogluconolactonase Activity in Brain Tumors In Vivo Using Hyperpolarized δ-[1- 13 C]gluconolactone

Frontiers in oncology, 2021-04, Vol.11, p.589570-589570

2021

Volltextzugriff (PDF)

Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in Glioma

Metabolites, 2021-02, Vol.11 (2), p.109

2021

Volltextzugriff (PDF)

HDAC inhibition in glioblastoma monitored by hyperpolarized 13C MRSI

NMR in biomedicine, 2019-02, Vol.32 (2), p.e4044-n/a

2019

Volltextzugriff (PDF)

Altered Surfactant Homeostasis and Alveolar Type II Cell Morphology in Mice Lacking Surfactant Protein D

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (20), p.11869-11874

1998

Volltextzugriff (PDF)

DIPG-90. NON-INVASIVE METABOLIC IMAGING OF DIFFUSE MIDLINE GLIOMAS AND THEIR RESPONSE TO THERAPY

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

IMG-31. DEUTERIUM METABOLIC IMAGING OF RESPONSE TO PRECISION THERAPY IN BRAF-V600E MUTANT GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

TMET-17. LEVERAGING METABOLIC VULNERABILITIES INDUCED BY TERT EXPRESSION FOR GLIOBLASTOMA THERAPY IN VIVO

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v276-v276

2023

Volltextzugriff (PDF)

Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer

Clinical cancer research, 2022-08, Vol.28 (16), p.3526-3536

2022

Volltextzugriff (PDF)

IMG-16. Non-invasive metabolic imaging of response to therapy in diffuse midline gliomas

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i80-i80

2022

Volltextzugriff (PDF)

TAMI-40. PEDIATRIC H3K27M MUTANT GLIOMAS UNDERGO METABOLIC REPROGRAMMING THAT CAN BE LEVERAGED FOR NON-INVASIVE METABOLIC IMAGING

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi206-vi207

2021

Volltextzugriff (PDF)

NIMG-51. DEUTERIUM METABOLIC IMAGING OF BRAIN TUMOR IMMORTALITY USING 2H-PYRUVATE

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi140-vi141

2021

Volltextzugriff (PDF)

BIOM-10. PRECLINICAL PLATFORM FOR THE IDENTIFICATION OF DEUTERIUM MAGNETIC RESONANCE SPECTROSCOPY-BASED BIOMARKERS OF BRAIN TUMOR METABOLISM

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi12-vi12

2021

Volltextzugriff (PDF)

Acquisition and quantification pipeline for in vivo hyperpolarized 13C magnetic resonance spectroscopy

Magnetic resonance in medicine, 2021-11, Vol.87 (4), p.1673-1687

2021

Volltextzugriff (PDF)

The Use of Transgenic and Mutant Mice to Study Oxygen Free Radical Metabolism

Annals of the New York Academy of Sciences, 1999-11, Vol.893 (1), p.95-112

1999

Volltextzugriff (PDF)

Superoxide-Mediated Cytotoxicity in Superoxide Dismutase-Deficient Fetal Fibroblasts

Archives of biochemistry and biophysics, 1997-08, Vol.344 (2), p.424-432

1997

Volltextzugriff (PDF)

PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival

Scientific reports, 2019-07, Vol.9 (1), p.10521-15, Article 10521

2019

Volltextzugriff (PDF)

TAMI-08. A TALE OF TWO TELOMERE MAINTENANCE MECHANISMS: TERT EXPRESSION AND THE ALT PATHWAY INDUCE UNIQUE MRS-DETECTABLE METABOLIC REPROGRAMMING IN LOW-GRADE GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii214-ii214

2020

Volltextzugriff (PDF)

Imaging telomerase reverse transcriptase expression in oligodendrogliomas using hyperpolarized δ-[1-13C]-gluconolactone

Neuro-oncology advances, 2023-01, Vol.5 (1), p.vdad092-vdad092

2023

Volltextzugriff (PDF)

EXTH-46. MRS BASED BIOMARKERS OF IDH1 MUTANT GLIOMA RESPONSE TO THE IDH INHIBITOR BAY-1436032

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi173-vi173

2021

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(91)
Dissertationen
(1)

Sprache

Englisch
(92)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Primary afferent tachykinins are required to experience moderate to intense pain

Acquisition and quantification pipeline for in vivo hyperpolarized 13C MR spectroscopy

Acquisition and quantification pipeline for in vivo hyperpolarized 13 C MR spectroscopy

Cell fate analysis in fetal mouse lung reveals distinct pathways for TI and TII cell development

Non-invasive assessment of telomere maintenance mechanisms in brain tumors

Hyperpolarized δ-[1- 13 C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastoma

Imaging 6-Phosphogluconolactonase Activity in Brain Tumors In Vivo Using Hyperpolarized δ-[1- 13 C]gluconolactone

Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in Glioma

HDAC inhibition in glioblastoma monitored by hyperpolarized 13C MRSI

Altered Surfactant Homeostasis and Alveolar Type II Cell Morphology in Mice Lacking Surfactant Protein D

DIPG-90. NON-INVASIVE METABOLIC IMAGING OF DIFFUSE MIDLINE GLIOMAS AND THEIR RESPONSE TO THERAPY

IMG-31. DEUTERIUM METABOLIC IMAGING OF RESPONSE TO PRECISION THERAPY IN BRAF-V600E MUTANT GLIOMAS

TMET-17. LEVERAGING METABOLIC VULNERABILITIES INDUCED BY TERT EXPRESSION FOR GLIOBLASTOMA THERAPY IN VIVO

Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer

IMG-16. Non-invasive metabolic imaging of response to therapy in diffuse midline gliomas

TAMI-40. PEDIATRIC H3K27M MUTANT GLIOMAS UNDERGO METABOLIC REPROGRAMMING THAT CAN BE LEVERAGED FOR NON-INVASIVE METABOLIC IMAGING

NIMG-51. DEUTERIUM METABOLIC IMAGING OF BRAIN TUMOR IMMORTALITY USING 2H-PYRUVATE

BIOM-10. PRECLINICAL PLATFORM FOR THE IDENTIFICATION OF DEUTERIUM MAGNETIC RESONANCE SPECTROSCOPY-BASED BIOMARKERS OF BRAIN TUMOR METABOLISM

Acquisition and quantification pipeline for in vivo hyperpolarized 13C magnetic resonance spectroscopy

The Use of Transgenic and Mutant Mice to Study Oxygen Free Radical Metabolism

Superoxide-Mediated Cytotoxicity in Superoxide Dismutase-Deficient Fetal Fibroblasts

PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival

TAMI-08. A TALE OF TWO TELOMERE MAINTENANCE MECHANISMS: TERT EXPRESSION AND THE ALT PATHWAY INDUCE UNIQUE MRS-DETECTABLE METABOLIC REPROGRAMMING IN LOW-GRADE GLIOMAS

Imaging telomerase reverse transcriptase expression in oligodendrogliomas using hyperpolarized δ-[1-13C]-gluconolactone

EXTH-46. MRS BASED BIOMARKERS OF IDH1 MUTANT GLIOMA RESPONSE TO THE IDH INHIBITOR BAY-1436032

Suchergebnisse filtern